Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention

Coronary Artery Disease

Volumn 25, Issue 1, 2014, Pages 79-82

  Pereg, David ^a,b,d   Elis, Avishay ^c,d   Neuman, Yoram ^b,d   Mosseri, Morris ^b,d   Segev, David ^f   Granek Catarivas, Martine ^d,e,f   Lishner, Michael ^c,d   Hermoni, Doron ^d,e,f  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Division of Cardiology   (Canada)

^c MEIR MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e Department of Family Medicine ^*  (United States)

^f CLALIT HEALTH SERVICES   (Israel)

Author keywords

coronary artery disease; mortality; peripheral artery disease

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SECONDARY PREVENTION; SMOKING; TREATMENT OUTCOME;

AGED; ANGIOPLASTY; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOWER EXTREMITY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84890555609     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000044     Document Type: Article

References (13)

1. Hackam DG, Tan MK, Lin PJ, Mehta PG, Jaffer S, Kates M, et al. Vascular Protection Registry; Guideline Oriented Approach in Lipid Lowering Registry Investigators. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries. J Vasc Surg 2006; 44:776-781.
2. Welten GM, Schouten O, Hoeks SE, Chonchol M, Vidakovic R, van Domburg RT, et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 2008; 51:1588-1596.
3. Hertzer NR. Basic data concerning associated coronary disease in peripheral vascular patients. Ann Vasc Surg 1987; 1:616-620.
4. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32:1769-1818.
5. Cacoub PP, Abola MT, Baumgartner I, Bhatt DL, Creager MA, Liau CS, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) registry. Atherosclerosis 2009; 204:e86-e92.
6. Kertai MD, Boersma E, Westerhout CM, van Domburg R, Klein J, Bax JJ, et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 2004; 116:96-103.
7. McDermott MM, Mandapat AL, Moates A, Albay M, Chiou E, Celic L, Greenland P. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med 2003; 163:2157-2162.
8. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286:1317-1324.
9. Hasimu B, Li J, Yu J, Ma W, Zhao M, Nakayama T, et al. Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients. Circ J 2007; 71:95-99.
10. McDermot MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997; 12:209-215.
11. Pereg D, Neuman Y, Elis A, Minha S, Mosseri M, Segev D, et al. Comparison of lipid control in patients with coronary versus peripheral artery disease following the first vascular intervention. Am J Cardiol 2012; 110: 1266-1269.
12. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004; 110:738-743.
13. Subherwal S, Patel MR, Kober L, Peterson ED, Jones WS, Gislason GH, et al. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation 2012; 126:1345-1354.